[Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2

Detalles Bibliográficos
Autores principales: Boira, Ignacio, Torba, Anastasiya, Castelló, Carmen, Esteban, Violeta, Vañes, Sandra, Chiner, Eusebi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SEPAR. Published by Elsevier España, S.L.U. 2022
Materias:
Letter to the Director
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005042/
http://dx.doi.org/10.1016/j.arbres.2022.01.021
_version_ 1784686380927942656
author Boira, Ignacio
Torba, Anastasiya
Castelló, Carmen
Esteban, Violeta
Vañes, Sandra
Chiner, Eusebi
author_facet Boira, Ignacio
Torba, Anastasiya
Castelló, Carmen
Esteban, Violeta
Vañes, Sandra
Chiner, Eusebi
author_sort Boira, Ignacio
collection PubMed
description
format Online
Article
Text
id pubmed-9005042
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SEPAR. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-90050422022-04-13 [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2 Boira, Ignacio Torba, Anastasiya Castelló, Carmen Esteban, Violeta Vañes, Sandra Chiner, Eusebi Arch Bronconeumol Letter to the Director SEPAR. Published by Elsevier España, S.L.U. 2022-04 2022-04-12 /pmc/articles/PMC9005042/ http://dx.doi.org/10.1016/j.arbres.2022.01.021 Text en © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Director
Boira, Ignacio
Torba, Anastasiya
Castelló, Carmen
Esteban, Violeta
Vañes, Sandra
Chiner, Eusebi
[Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
title [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
title_full [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
title_fullStr [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
title_full_unstemmed [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
title_short [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
title_sort [translated article] pleuropericardial effusion and systemic inflammatory syndrome secondary to the administration of the mrna-1273 vaccine for sars-cov-2
topic Letter to the Director
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005042/
http://dx.doi.org/10.1016/j.arbres.2022.01.021
work_keys_str_mv AT boiraignacio translatedarticlepleuropericardialeffusionandsystemicinflammatorysyndromesecondarytotheadministrationofthemrna1273vaccineforsarscov2
AT torbaanastasiya translatedarticlepleuropericardialeffusionandsystemicinflammatorysyndromesecondarytotheadministrationofthemrna1273vaccineforsarscov2
AT castellocarmen translatedarticlepleuropericardialeffusionandsystemicinflammatorysyndromesecondarytotheadministrationofthemrna1273vaccineforsarscov2
AT estebanvioleta translatedarticlepleuropericardialeffusionandsystemicinflammatorysyndromesecondarytotheadministrationofthemrna1273vaccineforsarscov2
AT vanessandra translatedarticlepleuropericardialeffusionandsystemicinflammatorysyndromesecondarytotheadministrationofthemrna1273vaccineforsarscov2
AT chinereusebi translatedarticlepleuropericardialeffusionandsystemicinflammatorysyndromesecondarytotheadministrationofthemrna1273vaccineforsarscov2

Ejemplares similares